1. DISEASE CHARACTERISTICS 1.1 Name of the disease (Synonyms) Mucopolysaccharidosis type II (MPS type II, MPS2, Hunter disease).
1.2 OMIM# of the disease 309900.
1.3 Name of the analysed genes or DNA/chromosome segments Iduronate 2-sulfatase (IDS).
OMIM# of the gene(s)
300823.
Mutational spectrum
Majority (B60%) point mutations, spread over the 9 exons, ca. 30% rearrangements affecting o20 nucleotides, ca. 10% rearrangements affecting 421 nucleotides, including a frequent and complex rearrangement due to homologous non-allelic recombination between the IDS gene and the neighbouring IDS pseudogene. 1 1.6 Analytical methods Bidirectional sequencing.
Analytical validation
Bidirectional sequencing; control of results by another set of PCR oligonucleotide primers or an alternative molecular genetic methods (eg restriction analysis, ASO-PCR etc); simultaneous analysis of family members (as positive and negative controls); comparison with database entries and data in the literature; quality control through sharing samples.
1.8 Estimated frequency of the disease (incidence at birth ('birth prevalence') or population prevalence) It is estimated to be 1.3 per 100 000 male newborns. 
Clinical sensitivity (proportion of positive tests if the disease is present)
The clinical sensitivity can be dependent on variable factors such as age or family history. In such cases a general statement should be given, even if a quantification can only be made case by case. Almost 100%.
Clinical specificity (proportion of negative tests if the disease is not present)
The clinical specificity can be dependent on variable factors such as age or family history. In such cases a general statement should be given, even if a quantification can only be made case by case. Practically 100%. 3.3 Genetic risk assessment in family members of a diseased person (To be answered if in 1.10 'C' was marked).
3.3.1 Does the result of a genetic test resolve the genetic situation in that family? Yes, X-linked inheritance.
Can a genetic test in the index patient save genetic or other tests in family members?
No, except for obligate carriers.
3.3.3 Does a positive genetic test result in the index patient enable a predictive test in a family member? Yes.
Prenatal diagnosis
(To be answered if in 1.10 'D' was marked).
3.4.1 Does a positive genetic test result in the index patient enable a prenatal diagnosis? Yes.
IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING
Please assume that the result of a genetic test has no immediate medical consequences. Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives? (Please describe).
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